ArticleWorld journal of microbiology & biotechnology2026
Preliminary study on the modulation of diet-induced malnutrition in BALB/c mice using a probiotic consortium: a physiological, biochemical, histopathological, and gut microbiota evaluation.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein-energy malnutrition (PEM) remains a major global health challenge that adversely affects growth, metabolism, immune function, and organ integrity. This study evaluated the efficacy of a food-derived Bacillus-based probiotic consortium in alleviating PEM and investigated its effects on gut microbial composition in BALB/c mice. Forty-eight male mice were allocated to Control (C), Disease Control (DC), Treatment (TG), Preventive (PG), and Healthy + Probiotic (HPG) groups. Malnutrition was induced using a 4% low-protein diet (LPD) for six weeks. The TG received probiotic supplementation during the recovery phase (weeks 6-9), whereas PG and HPG received probiotics throughout the study. The consortium consisted of Bacillus spizizenii, Bacillus tequilensis, and Bacillus rugosus (1 × 10⁹ CFU/mL each).LPD feeding significantly reduced body weight, total protein, albumin, cholesterol, and alkaline phosphatase activity while increasing C-reactive protein, serum glutamic oxaloacetic transaminase (SGOT), and serum glutamic pyruvic transaminase (SGPT), indicating metabolic impairment, systemic inflammation, and hepatic stress. Probiotic supplementation during nutritional rehabilitation significantly improved body weight gain, restored protein and albumin levels, normalized alkaline phosphatase activity, and reduced inflammatory and hepatic injury markers compared with dietary rehabilitation alone. Histopathological analyses demonstrated improved intestinal architecture, hepatocyte morphology, splenic organization, and renal integrity in the treatment group, whereas preventive supplementation under continued protein restriction resulted in only limited protection.Gut microbiota profiling using 16 S rRNA amplicon sequencing revealed that all groups were dominated by the phyla Bacteroidetes and Firmicutes. The treatment group exhibited increased relative abundance of beneficial taxa, including Barnesiella and Lactobacillus, together with reduced Proteobacteria abundance compared with the preventive group. Microbial community composition in the treatment group more closely resembled that of healthy animals, suggesting partial restoration of gut microbial homeostasis during nutritional rehabilitation.Collectively, these findings indicate that probiotic supplementation is most effective when combined with adequate nutritional support and may serve as a valuable adjunct strategy for improving physiological recovery, tissue regeneration, and gut microbial balance during protein-energy malnutrition.
Indexed as
Identifiers
42479266What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.